Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 1863 entries
View as:

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00045448 Org: User:
Start: 04/30/02 End: 12/31/09 Due: 12/31/10

Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging

Phase: N/A Priority: Normal
NCT ID: NCT00612326 Org: User:
Start: 06/30/04 End: 03/31/08 Due: 03/31/09

Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03465891 Org: User:
Start: 03/09/18 End: 12/17/19 Due: 12/17/20

Risk Factors for Endometrial Cancer in Black Women

Phase: N/A Priority: Normal
NCT ID: NCT00514254 Org: User:
Start: 07/31/07 End: 07/31/25 Due: 07/31/26

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04468841 Org: User:
Start: 07/08/20 End: 07/31/25 Due: 07/31/26

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01763606 Org: User:
Start: 12/18/12 End: 04/03/19 Due: 04/03/20

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Phase: N/A Priority: Normal
NCT ID: NCT05868265 Org: User:
Start: 06/02/23 End: 06/02/26 Due: 06/02/27

Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02227667 Org: User:
Start: 12/02/14 End: 06/29/20 Due: 06/29/21

Researching the Effect of Exercise on Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04589468 Org: User:
Start: 10/02/20 End: 10/02/25 Due: 10/02/26

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

Phase: N/A Priority: Normal
NCT ID: NCT05737615 Org: User:
Start: 02/10/23 End: 02/10/26 Due: 02/10/27

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04878094 Org: User:
Start: 05/03/21 End: 05/03/26 Due: 05/03/27

Reconstructive Surgery For Head And Neck Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00578032 Org: User:
Start: 12/31/07 End: 10/31/17 Due: 10/31/18

A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05889091 Org: User:
Start: 05/16/23 End: 05/16/26 Due: 05/16/27

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00027560 Org: User:
Start: 07/31/01 End: 04/30/09 Due: 04/30/10

Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)

Phase: N/A Priority: Normal
NCT ID: NCT04095234 Org: User:
Start: 09/17/19 End: 09/30/25 Due: 09/30/26

Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns

Phase: N/A Priority: Normal
NCT ID: NCT00518050 Org: User:
Start: 10/31/06 End: 07/31/15 Due: 07/31/16

Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00714948 Org: User:
Start: 07/31/08 End: 11/30/11 Due: 11/30/12

Depression Screening in Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00404365 Org: User:
Start: 04/30/06 End: 04/30/12 Due: 04/30/13

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT04162015 Org: User:
Start: 11/12/19 End: 11/30/26 Due: 11/30/27

Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission

Phase: N/A Priority: Normal
NCT ID: NCT00522301 Org: User:
Start: 07/31/07 End: 03/31/08 Due: 03/31/09

Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT00667615 Org: User:
Start: 04/30/08 End: 02/28/17 Due: 02/28/18

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00067015 Org: User:
Start: 05/31/03 End: 09/30/08 Due: 09/30/09

A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03290950 Org: User:
Start: 09/25/17 End: 09/30/25 Due: 09/30/26

Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT02697383 Org: User:
Start: 02/29/16 End: 05/08/24 Due: 05/08/25

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00620243 Org: User:
Start: 06/30/04 End: 11/30/08 Due: 11/30/09